Nanjing Heron Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Nanjing Heron Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 16 active records with this name as holder; 14 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
30 acceptance records as first applicant, grouped into 18 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
艾地骨化醇片 · No verified English name 2 records · Latest accepted 2026/10/22
Generic · 2
Drotaverine Hydrochloride Tablets 1 records · Latest accepted 2026/01/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600310 | Generic | 2026/01/29 | Nanjing Heron Pharmaceutical Co., Ltd.; Yao Da Pharmaceutical Co., Ltd. romanized | CDE ↗ |
依伏卡塞片 · No verified English name 2 records · Latest accepted 2025/12/31
Generic · 2
Calcipotriol Ointment 1 records · Latest accepted 2025/10/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503623 | Generic | 2025/10/11 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
Menatetrenone Soft Capsules 1 records · Latest accepted 2025/09/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503494 | Generic | 2025/09/23 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
Pemafibrate Tablets 1 records · Latest accepted 2025/09/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503306 | Generic | 2025/09/06 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
Ketorolac Trometamol Tablets 1 records · Latest accepted 2025/06/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502133 | Generic | 2025/06/14 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
Doxercalciferol Injection 1 records · Latest accepted 2024/10/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403349 | Generic | 2024/10/10 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
Cetrorelix Acetate for Injection 1 records · Latest accepted 2024/07/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402278 | Generic | 2024/07/20 | Nanjing Heron Pharmaceutical Co., Ltd.; Jiangsu Li Tai Er Pharma Co., Ltd. romanized | CDE ↗ |
Phenylephrine Hydrochloride Injection 2 records · Latest accepted 2024/06/26
Supplement · 2
Bupivacaine Hydrochloride Injection 2 records · Latest accepted 2023/11/22
Generic · 2
Paricalcitol Injection 1 records · Latest accepted 2023/10/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302256 | Supplement | 2023/10/12 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
Calcitriol Injection 3 records · Latest accepted 2023/09/26
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302587 | Generic | 2023/09/26 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2302586 | Generic | 2023/09/26 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101014 | Generic | 2021/03/03 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
Eldecalcitol Soft Capsules 2 records · Latest accepted 2023/07/04
Supplement · 2
Calcitriol Soft Capsules 3 records · Latest accepted 2023/04/25
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300882 | Supplement | 2023/04/25 | Nanjing Heron Pharmaceutical Co., Ltd.; An Shi Pharmaceutical (Zhong Shan) Co., Ltd. romanized | CDE ↗ |
| CYHS2101215 | Generic | 2021/06/07 | Nanjing Heron Pharmaceutical Co., Ltd.; An Shi Pharmaceutical (Zhong Shan) Co., Ltd. romanized | CDE ↗ |
| CYHS2101214 | Generic | 2021/06/07 | Nanjing Heron Pharmaceutical Co., Ltd.; An Shi Pharmaceutical (Zhong Shan) Co., Ltd. romanized | CDE ↗ |
Alfacalcidol Soft Capsules 2 records · Latest accepted 2021/09/16
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101743 | Generic | 2021/09/16 | Nanjing Heron Pharmaceutical Co., Ltd.; An Shi Pharmaceutical (Zhong Shan) Co., Ltd. romanized | CDE ↗ |
| CYHS2101742 | Generic | 2021/09/16 | Nanjing Heron Pharmaceutical Co., Ltd.; An Shi Pharmaceutical (Zhong Shan) Co., Ltd. romanized | CDE ↗ |
Ketorolac Tromethamine Injection 2 records · Latest accepted 2021/06/25
Generic · 2
Alfacalcidol Tablets 2 records · Latest accepted 2021/04/30
Generic · 2
Changes in the last 90 days
1 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 1 application
- 2026/10/22Accepted
艾地骨化醇片 · No verified English name
CYHS2602592
Fact date: 2026/10/22 · Date added to this site: 2026/10/22
View source ↗
Under review
9 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 艾地骨化醇片 · No verified English name | CYHS2602592 | Generic | 2026/10/22 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| 艾地骨化醇片 · No verified English name | CYHS2601641 | Generic | 2026/07/09 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Drotaverine Hydrochloride Tablets | CYHS2600310 | Generic | 2026/01/29 | Nanjing Heron Pharmaceutical Co., Ltd.; Yao Da Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| 依伏卡塞片 · No verified English name | CYHS2504512 | Generic | 2025/12/31 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| 依伏卡塞片 · No verified English name | CYHS2504511 | Generic | 2025/12/31 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Calcipotriol Ointment | CYHS2503623 | Generic | 2025/10/11 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Menatetrenone Soft Capsules | CYHS2503494 | Generic | 2025/09/23 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Pemafibrate Tablets | CYHS2503306 | Generic | 2025/09/06 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Ketorolac Trometamol Tablets | CYHS2502133 | Generic | 2025/06/14 | Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
16 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Doxercalciferol Injection | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20263827 | 2026/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cetrorelix Acetate for Injection | Nanjing Heron Pharmaceutical Co., Ltd. | Jiangsu Li Tai Er Pharma Co., Ltd. romanized | 国药准字H20263289 | 2026/02/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bupivacaine Hydrochloride Injection | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20253664 | 2025/03/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bupivacaine Hydrochloride Injection | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20253665 | 2025/03/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcitriol Injection | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20249682 | 2024/12/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcitriol Injection | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20249716 | 2024/12/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paricalcitol Injection | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20234752 | 2023/12/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eldecalcitol Soft Capsules | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20234466 | 2023/11/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eldecalcitol Soft Capsules | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20234465 | 2023/11/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alfacalcidol Tablets | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20233522 | 2023/05/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alfacalcidol Tablets | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20233523 | 2023/05/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Thioctic Acid Injection | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20233432 | 2023/04/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Thioctic Acid Injection | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20233431 | 2023/04/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcitriol Soft Capsules | Nanjing Heron Pharmaceutical Co., Ltd. | An Shi Pharmaceutical (Zhong Shan) Co., Ltd. romanized | 国药准字H20233222 | 2023/02/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcitriol Soft Capsules | Nanjing Heron Pharmaceutical Co., Ltd. | An Shi Pharmaceutical (Zhong Shan) Co., Ltd. romanized | 国药准字H20247023 | 2023/02/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ketorolac Tromethamine Injection | Nanjing Heron Pharmaceutical Co., Ltd. | Nanjing Heron Pharmaceutical Co., Ltd. | 国药准字H20223467 | 2022/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
14 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 托伐普坦磷酸钠 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20260000113 | I | 2026/03/06 | CDE ↗ |
| 依伏卡塞 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20250001287 | I | 2025/12/08 | CDE ↗ |
| 佩玛贝特 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20250000653 | I | 2025/07/04 | CDE ↗ |
| 度骨化醇 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20240000985 | A | 2026/05/20 | CDE ↗ |
| 醋酸西曲瑞克 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20230001331 | A | 2025/08/22 | CDE ↗ |
| 盐酸尼卡地平 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20230001148 | A | 2025/07/04 | CDE ↗ |
| 卡泊三醇 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20230000467 | A | 2025/12/31 | CDE ↗ |
| 帕立骨化醇 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20210001141 | A | 2026/01/06 | CDE ↗ |
| 艾地骨化醇 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20210000737 | A | 2026/10/28 | CDE ↗ |
| 酮咯酸氨丁三醇 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20210000317 | A | 2024/12/27 | CDE ↗ |
| 骨化三醇 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20210000028 | A | 2025/04/04 | CDE ↗ |
| 瑞加诺生 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20200000551 | A | 2026/05/22 | CDE ↗ |
| 他卡西醇 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20180001179 | A | 2025/11/05 | CDE ↗ |
| 阿法骨化醇 · No verified English name | Nanjing Heron Pharmaceutical Co., Ltd. | Y20180000715 | A | 2025/03/23 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
13 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| HR1405-01注射液 · No verified English name | CXHB2500158 | Supplement | 2025/05/30 | Nanjing Hai Rong Pharmaceuticals Technology Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Regadenoson Injection | CXHS2500024 | New drug | 2025/03/19 | Nanjing Rui Ke Wei Biopharmaceuticals Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Thioctic Acid Injection | CYHB2401043 | Supplement | 2024/07/16 | Nanjing Rui Ke Wei Biopharmaceuticals Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Thioctic Acid Injection | CYHB2401042 | Supplement | 2024/07/16 | Nanjing Rui Ke Wei Biopharmaceuticals Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Nicardipine Hydrochloride Injection | CYHS2400566 | Generic | 2024/02/08 | Nanjing Rui Zhi Biopharmaceuticals Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Thioctic Acid Injection | CYHB2301643 | Supplement | 2023/07/19 | Nanjing Rui Ke Wei Biopharmaceuticals Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Thioctic Acid Injection | CYHB2301642 | Supplement | 2023/07/19 | Nanjing Rui Ke Wei Biopharmaceuticals Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Phenylephrine Hydrochloride Injection | CYHS2300323 | Generic | 2023/02/03 | Nanjing Hai Rong Pharmaceuticals Technology Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Phenylephrine Hydrochloride Injection | CYHS2300321 | Generic | 2023/02/03 | Nanjing Hai Rong Pharmaceuticals Technology Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Paricalcitol Injection | CYHS2201089 | Generic | 2022/07/18 | Nanjing Hai Rong Pharmaceuticals Technology Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Eldecalcitol Soft Capsules | CYHS2200325 | Generic | 2022/02/17 | Nanjing Hai Rong Pharmaceuticals Technology Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Eldecalcitol Soft Capsules | CYHS2200324 | Generic | 2022/02/17 | Nanjing Hai Rong Pharmaceuticals Technology Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
| Regadenoson Injection | CYHB2102143 | Supplement | 2021/11/17 | Nanjing Rui Ke Wei Biopharmaceuticals Co., Ltd. romanized; Nanjing Heron Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.